Celmoleukin
Celmoleukin | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Celmoleukin is a biological response modifier that acts as an interleukin-based therapeutic agent. It is primarily used in the treatment of certain autoimmune diseases and cancers. Celmoleukin functions by modulating the immune system, enhancing the body's natural defense mechanisms against pathological conditions.
Mechanism of Action
Celmoleukin is a recombinant form of interleukin, a type of cytokine that plays a crucial role in the immune system. It binds to specific receptors on the surface of immune cells, such as T cells and natural killer cells, activating them to proliferate and attack abnormal cells. This activation leads to an enhanced immune response, which can be beneficial in targeting cancer cells or modulating autoimmune responses.
Clinical Applications
Celmoleukin has been investigated for its potential in treating various conditions, including:
- Rheumatoid arthritis: By modulating the immune response, Celmoleukin can reduce inflammation and joint damage.
- Melanoma: It enhances the immune system's ability to recognize and destroy cancer cells.
- Multiple sclerosis: Celmoleukin may help in reducing the frequency and severity of relapses by modulating immune activity.
Side Effects
Common side effects of Celmoleukin include flu-like symptoms, such as fever, chills, and fatigue. More severe side effects can include cytokine release syndrome, which requires careful monitoring and management.
Research and Development
Ongoing research is focused on optimizing the delivery and efficacy of Celmoleukin, as well as expanding its use to other types of cancer and autoimmune diseases. Clinical trials are exploring combination therapies with other immunomodulatory agents to enhance therapeutic outcomes.
Also see
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD